About this trial
In the past few years, periosteal membrane has been used in orthopedic surgery as well as periodontal surgery as a mechanism to promote bone healing without the ingrowth of fibrous tissues. It has shown its efficiency in maintaining the bone volume and density in postoperative follow up. This can in turn solve the problem of potential bone loss in patients of alveolar cleft.
The study aims to see if fixing the periosteum of the anterior ilium with tacks after bone graft application in the donor site will help maintain the graft and promote healing for the alveolar cleft patients
Eligibility criteria
Qualifiers
9 -12 years, depending on dental age not chronological.
systemically healthy patients (American Society of Anesthesiologists -ASA I and II)
Patients secondary alveolar cleft patient.
Disqualifiers
Patients with recurrent palatal fistula.
Existence of syndromic cleft palate.
Patient with uncontrolled systematic disease.
Patients undergoing radiotherapy or chemotherapy for malignancy.
Trial design
Treatments tested in this trial
- : delayed surgical repair of alveolar cleft using particulate cortico-cancellous anterior iliac bon
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.